Open Nav

Doane Chilcoat

Director, Applied Science & Technology

Corteva Agriscience™, agriculture division of DowDuPont™

Dr. Chilcoat leads the Applied Science & Technology (AST) organization at Corteva Agriscience, Agriculture Division of DowDuPont. His responsibilities include vector construction, protein engineering, genome engineering (traditional transformation and use of CRISPR/Cas9 technology), genomics, greenhouses/controlled environments, high-throughput macromolecular analysis, protein production, analytic chemistry, and chemometrics (including remote sensing). AST supports the entire R&D portfolio and provides DNA sequencing for all of DowDuPont. AST includes more than 300 researchers at multiple global sites.

AST is a leader in the development and deployment of CRISPR/Cas9 based genome editing technology.

Recent highlights include:

•Use of CRISPR/Cas to improve grain composition and drought tolerance in maize

•Discovery of Cas9 proteins with novel properties

•Development of a new off-site detection method

•The first demonstration of RNP based (DNA free) editing in crop plants

Prior to taking his current role in June 2011, Doane was CEO and cofounder of an anti-infective biotech focused on the human microbiome, Cobax Biopharma. Before that he was Senior Director of Sales Operations at Replidyne, a public biotechnology company. He previously was an associate partner with McKinsey and Company in Chicago and Los Angeles, with a practice that focused on life science companies: agriculture, biochemical reagents, and pharma/biotech. Doane received his B.A. in Biology from Grinnell College and his Ph.D. in Molecular Genetics and Cell Biology from the University of Chicago.

This speaker's sessions: